1518 Diabetes Care Volume 38, August 2015

Size: px
Start display at page:

Download "1518 Diabetes Care Volume 38, August 2015"

Transcription

1 1518 Diabetes Care Volume 38, August 2015 Impact of Socioeconomic Status on Cardiovascular Disease and Mortality in 24,947 Individuals With Type 1 Diabetes Diabetes Care 2015;38: DOI: /dc Araz Rawshani, 1,2 Ann-Marie Svensson, 2,3 Annika Rosengren, 1,2 Björn Eliasson, 1,2 and Soffia Gudbjörnsdottir 2,3 CARDIOVASCULAR AND METABOLIC RISK OBJECTIVE Socioeconomic status (SES) is a powerful predictor of cardiovascular disease (CVD) and death. We examined the association in a large cohort of patients with type 1 diabetes. RESEARCH DESIGN AND METHODS Clinical data from the Swedish National Diabetes Register were linked to national registers, whereby information on income, education, marital status, country of birth, comorbidities, and events was obtained. Patients were followed until a first incident event, death, or end of follow-up. The association between socioeconomic variables and the outcomes was modeled using Cox regression, with rigorous covariate adjustment. RESULTS We included 24,947 patients. Mean (SD) age and follow-up was 39.1 (13.9) and 6.0 (1.0) years. Death and fatal/nonfatal CVD occurred in 926 and 1378 individuals. Compared with being single, being married was associated with 50% lower risk of death, cardiovascular (CV) death, and diabetes-related death. Individuals in the two lowest quintiles had twice as great a risk of fatal/nonfatal CVD, coronary heart disease, and stroke and roughly three times as great a risk of death, diabetesrelated death, and CV death as individuals in the highest income quintile. Compared with having 9 years of education, individuals with a college/university degree had 33% lower risk of fatal/nonfatal stroke. Immigrants had 19%, 33%, and 45% lower risk of fatal/nonfatal CVD, all-cause death, and diabetes-related death, respectively, compared with Swedes. Men had 44%, 63%, and 29% greater risk of all-cause death, CV death, and diabetes-related death. CONCLUSIONS Low SES increases the risk of CVD and death by a factor of 2 3intype1diabetes. Socioeconomic status (SES) is a complex construct, often conceptualized as the social standing or class of an individual. It is commonly measured as a combination of education, income, and occupation but may include age, sex, ethnicity, and marital status (1). SES may profoundly affect health. It is a powerful predictor of cardiovascular disease (CVD) and death (2 5). The impact of SES on CVD and mortality in type 2 diabetes has been examined (6), but studies in type 1 diabetes are scarce. Available data, which are hampered by 1 Sahlgrenska University Hospital, Gothenburg, Sweden 2 Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg, Sweden 3 National Diabetes Register, Centre of Registers, Gothenburg, Sweden Corresponding author: Araz Rawshani, araz. rawshani@gu.se. Received 20 January 2015 and accepted 28 March This article contains Supplementary Data online at suppl/doi: /dc /-/dc1. A slide set summarizing this article is available online by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.

2 care.diabetesjournals.org Rawshani and Associates 1519 small samples and inadequate adjustment for confounders, suggest either a modest effect or no significant effect of SESondeathandCVD(7 9). Consequently, no reliable studies relating SES to CVD and mortality in type 1 diabetes have been conducted. This might explain why socioeconomic variables have not been considered in recent risk prediction models for type 1 diabetes (10,11). We used the Swedish National Diabetes Register (NDR), which provides almost complete national coverage of type 1 diabetes, to investigate how income, education, marital status, immigrant status, and sex relate to CVD and death (12,13). It is important to examine this relationship, as it may reveal easily accessible risk markers. RESEARCH DESIGN AND METHODS The NDR was initiated in 1996 as a caregiver tool for local quality assurance and as a feedback tool in diabetes care. Roughly 95% of all individuals age 18 years and older with type 1 diabetes in Sweden are included (12). Data provided by nurses and physicians trained in register procedures are obtained at visits in outpatient clinics of hospitals and primary health care centers nationwide. Clinical information and various measurements are updated at least once a year. The study was approved by the regional ethics review board at the University of Gothenburg. All patients give their informed consent before being included in the NDR. Study Cohort We included 24,947 individuals (220,281 appointments) with type 1 diabetes who had at least one listing in the NDR between 1 January 2006 and 31 December This excluded 2,186 individuals with a history of CVD (as defined below), who were listed in the NDR during the same period. Type 1 diabetes was definedonthebasisof epidemiologic data: treatment with insulin and a diagnosis at the age of 30 years or younger. This definition has been validated as accurate in 97% of the cases listed in the register (14). Socioeconomic Data Data on annual income in Swedish kronor, highest educational level, country of birth, marital status, and occupation were obtained from Statistics Sweden. Education was stratified into lower (#9 years, the length of compulsory education in Sweden), intermediate (10 12 years, upper secondary) and higher (college/university). Income was stratified into quintiles (Q1 [lowest] to Q5 [highest]). Immigrant status was defined as immigrant or native Swede depending on country of birth. Marital categories were single (defined as never married and not cohabiting), married/cohabiting, divorced, or widowed. We decided beforehand to omit occupation from the analyses, assuming that income, education, immigrant status, and marital status were sufficient socioeconomic indicators. Socioeconomic variables were updated annually. Clinical Data BMI was calculated as weight in kilograms divided by the square of height in meters. Glycemic control was measured as HbA 1c. Analyses were quality assured nationwide by regular calibration with the high-performance liquid chromatography Mono-S method and then converted to millimoles per mole (IFCC) (22). LDL, HDL, and total cholesterol were measured in millimoles per liter. Microalbuminuria was defined as two positive tests out of three samples taken within a year, with albuminto-creatinine ratio 3 30 mg/mmol or a urinary albumin clearance of mg/min or mg/l, and macroalbuminuria as albumin-to-creatinine ratio.30 mg/mmol or a urinary albumin clearance of.200 mg/min or.300 mg/l. Glomerular filtration rate was estimated(egfr)withthemdrdequation (15). Systolic blood pressure was the mean value of two supine readings (Korotkoff 1 5) with a cuff of appropriate size and after at least 5 min of rest. Method of insulin delivery was defined as either multiple daily injections or use of continuous subcutaneous insulin infusion (CSII). Use of lipid-lowering medications, blood pressure lowering medications, and aspirin was dichotomized. Smoking was coded as present if the patient was a current smoker. Physical activity (for at least 30 min) was rated from 1 to 5: never (level 1), less than once a week (level 2), once or twice a week (level 3), 3 5 times per week (level 4), or daily (level 5). Time-varying variables were updated for each appointment in the NDR. Comorbidities, Events, and Vital Status Comorbidities and events were collected before baseline examination and during follow-up by linking data from the NDR to the Swedish Inpatient Registry (IPR) and the Causes of Death Registry. The IPR was initiated in the 1960s and has nationwide coverage since It includes mandatory information on all principal and secondary hospital discharge diagnoses. The ICD system is used to classify diagnoses in the IPR. Sensitivity and specificity for diagnoses of acute myocardial infarction, coronary heart disease (CHD), hospitalization for heart failure (HF), atrial fibrillation (AF), and stroke have been validated (16,17). The following comorbidities were assessed: HF (ICD-10 code I50, ICD-9 code 428), AF (ICD-10 code I48, ICD-9 code 427D), any cancer (ICD-10 codes C00-C97, ICD-9 codes ), and mental disorders (ICD-10 codes F20 29 and F30 39). The following codes were used for renal dialysis and transplantation: V42A, V45B, V56A, V56 W (ICD-9), and Z94.0, Z49, and Z99.2 (ICD-10). Stage 5 chronic kidney disease was defined as the need for renal dialysis or renal transplantation or as an egfr of,15 ml/min. Nonfatal CHD was defined as nonfatal myocardial infarction (ICD-10 code I21), unstable angina (ICD-10 code I20.0), percutaneous coronary intervention, or coronary artery bypass grafting. Fatal CHD was defined as ICD-10 codes I20-I25. Stroke was defined as nonfatal or fatal cerebral infarction, intracerebral hemorrhage, or unspecified stroke (ICD-10 codes I61 I64). CVD was defined as the composite of CHD or strokedwhichever came first. Cardiovascular (CV) mortality was defined as I00 I99 and diabetesrelated death as E10 E14. All individuals were followed from the baseline examination until a first incident event or death or otherwise until the censor date of 31 December Mean (SD) follow-up was 6.0 (1.0) years with 150,541 person-years of follow-up. Statistical Methods Baseline clinical features were calculated as mean (SD) values or percentages for each variable in relation to income, education, marital status, immigrant status, and sex. Survival Analyses Crude event rates were described as events per 1,000 person-years. Cox

3 1520 Report by the Swedish National Diabetes Register Diabetes Care Volume 38, August 2015 proportional hazards model was used to study relations between patients characteristics and the outcome. Two sequential models were developed to estimate the effect of socioeconomic factors on the risk of 1) fatal/nonfatal CVD, 2) fatal/ nonfatal CHD, 3) fatal/nonfatal stroke, 4) total death, 5) CV death and 6) diabetesrelated death. We adjusted for known and presumed risk factors and confounders for each outcome. The first model, which we refer to as the minimally adjusted model, was identical for all outcomes and included socioeconomic, demographic, and diabetes-related variables. The second model, which we refer to as the maximally adjusted model, was additionally adjusted for outcome specificcovariates. Minimally Adjusted Models Sex, immigrant status, age at inclusion, anddurationofdiabetesatinclusion were included in all models and held fixed. We used restricted cubic splines (five knots placed at the 5th, 27.5th, 50th, 72.5th, and 95th percentiles) to model the association between age and the outcome. Income quintile, marital status, and educational level were also included in all models as time-varying covariates. Maximally Adjusted Models Variables in the maximally adjusted models were entered as time-dependent covariates from baseline until an event, death, or the end of the study. Fatal/ nonfatal CVD was additionally adjusted for smoking, systolic blood pressure, HbA 1c, physical activity, egfr, albuminuria, total cholesterol to HDL ratio, antihypertensives, statins, and aspirin. Fatal/nonfatal CHD and fatal/nonfatal stroke were adjusted for the same covariates. All-cause death and CV death were additionally adjusted for smoking, HbA 1c, physical activity, egfr, CVD, albuminuria, and HF. Diabetes-related death was additionally adjusted for smoking status, systolic blood pressure, HbA 1c, physical activity, egfr, chronic kidney disease, and albuminuria. Given that sex is an important component of social position, we present hazard ratios (HR) for sex, using females as the reference group. For all-cause death, we calculated Cox adjusted survival curves according to socioeconomic categories. We adjusted for age and duration of diabetes. We assessed the proportional hazard assumption for all variables by using Schoenfeld residuals. No significant interactions were found between the socioeconomic variables and the covariates in the final model. Modeling Time-Dependent Covariates As explained above, some variables were modeled as time-dependent covariates. This is appropriate, since we had access to updated measurements of the covariates that change during follow-up. The course of the covariates might be more informative of the survival experience than their baseline values. Cox s model can be generalized to include time-dependent covariates and thus take all data into account. Technically, this is carried out by requiring that each time period for a patient appear as a separate observation in the data set. Missing Data We addressed missing data in two steps. Firstly, we used last observation carried forward to impute missing variables if previous measurements existed. Supplementary Table 1 presents the proportion of missing data after last observation carried forward. Secondly, we used multiple imputation by chained equations. Multiple imputation was performed according to guidelines (18) by means of the MICE (Multivariate Imputation by Chained Equations) algorithm. We imputed five data sets (using 10 iterations) (19). RESULTS Baseline Clinical Features Immigrants and native Swedes were comparable in terms of both age and sex (Table 1). Immigrants, however, had lower income, were twice as likely to be smokers, were less physically active, and tended more to be married/ cohabiting. With respect to marital status, there were large differences in terms of age, rendering the baseline comparisons difficult to assess (Table 1). However, individuals who were married/cohabiting were fairly comparable with those who were divorced with regard to age and sex. Individuals who were divorced tended to be women, had higher HbA 1c, were twice as likely to be smokers, had albuminuria more often, and were less physically active. Individuals with years of education were comparable at baseline (considering distribution of age and sex) with those with a college/university degree (Table 2). Individuals with a college/university degree had higher income, had 5 mmol/mol lower HbA 1c, were more likely to be married/cohabiting, used insulin pump more frequently (17.5% vs. 14.5%), smoked less (5.8% vs. 13.1%), and had less albuminuria (10.8% vs. 14.2%). Income Q2, Q3, and Q4 were approximately of the same age. Individuals with high income were more likely to be married/cohabiting, had lower HbA 1c,and had lower rates of smoking as well as albuminuria (Table 2). With respect to sex, men and women were roughly the same age. Women had substantially lower income and higher education, were more often married, used insulin pump more frequently, had less albuminuria, and smoked more frequently than men (Supplementary Table 2). Crude Incidence Rates The number of events and the crude incidence rates are presented in Supplementary Table 3. Low income, low education, and being divorced or widowed were all associated with higher incidence rates of all outcomes. Refer to Supplementary Table 3 for incidence rates. Age- and Sex-Adjusted Survival Curves Cox adjusted survival curves for death (Supplementary Fig. 1A D) indicated that income, education, marital status, and immigrant status were significantly (all P, 0.05) associated with survival. Adjusted HRs for the Outcomes Marital Status Compared with being single (the reference category for marital status), being married/cohabiting did not affect the risk of fatal/nonfatal CVD, fatal/nonfatal CHD, or fatal/nonfatal stroke(fig.1). Being married/cohabiting was associated with 50 64% lower risk of all-cause death, CV death, and diabetes-related death (Fig. 2 [maximally adjusted models]). Being divorced increased the risk of fatal/ nonfatal CVD by 32%. The same tendency was noted for fatal/nonfatal CHD and stroke but without statistical significance (Fig. 1) (maximally adjusted models). Being divorced was associated with 40% lower risk of CV death compared with being single (Fig. 2) (maximally adjusted model). Being widowed was associated with

4 care.diabetesjournals.org Rawshani and Associates 1521 Table 1 Characteristics of the cohort at baseline, according to marital status and immigrant status Marital status Immigrant status Single Divorced Married/cohabiting Widowed Swedish native Immigrant Individuals, n 13,560 2,266 8, ,382 1,565 Males 7,863 (58.0) 1,058 (46.7) 4,411 (50.1) 71 (24.1) 12,659 (54.1) 756 (48.3) Age (years) (10.87) (10.58) (12.11) (11.22) (13.93) (12.74) Onset age (years) (7.41) (7.93) (7.82) (7.58) (7.67) (7.42) Income, n (%) Q1 4,036 (29.8) 265 (11.7) 1,430 (16.2) 64 (21.8) 5,242 (22.4) 553 (35.6) Q2 2,759 (20.3) 545 (24.1) 1,417 (16.1) 84 (28.6) 4,491 (19.2) 314 (20.2) Q3 2,604 (19.2) 487 (21.5) 1,669 (19.0) 39 (13.3) 4,505 (19.3) 294 (18.9) Q4 2,350 (17.3) 471 (20.8) 1,844 (21.0) 42 (14.3) 4,490 (19.2) 217 (14.0) Q5 1,811 (13.4) 498 (22.0) 2,440 (27.7) 65 (22.1) 4,637 (19.8) 177 (11.4) Education, n (%) #9 years 2,037 (15.2) 483 (21.4) 1,415 (16.1) 117 (40.2) 3,707 (15.9) 345 (23.3) years 7,507 (55.9) 1,210 (53.5) 4,292 (49.0) 124 (42.6) 12,466 (53.6) 667 (45.0) College/university 3,877 (28.9) 567 (25.1) 3,055 (34.9) 50 (17.2) 7,080 (30.4) 469 (31.7) Marital status, n (%) Single N/A N/A N/A N/A 12,967 (55.5) 593 (38.1) Divorced N/A N/A N/A N/A 2,047 (8.8) 219 (14.1) Married/cohabiting a N/A N/A N/A N/A 8,078 (34.6) 722 (46.4) Widowed N/A N/A N/A N/A 273 (1.2) 21 (1.4) Immigrant, n (%) 593 (4.4) 219 (9.7) 722 (8.2) 21 (7.1) N/A N/A CSII, n (%) 1,750 (14.7) 221 (11.3) 1,210 (15.5) 17 (6.5) 3,093 (14.9) 110 (9.1) HbA 1c (mmol/mol) (15.74) (14.39) (13.04) (11.68) (14.59) (16.54) egfr (ml/min) (27.69) (28.15) (24.87) (22.31) (26.95) (34.0) Systolic BP (mmhg) (14.53) (16.83) (16.26) (18.01) (15.77) (16.6) Chol-to-HDL ratio 3.18 (1.05) 3.10 (1.03) 3.04 (1.00) 2.89 (0.84) 3.11 (1.02) 3.30 (1.13) BMI (kg/m 2 ) (4.35) (4.38) (4.19) (4.87) (4.26) (4.98) Smoker, n (%) 1,670 (12.9) 429 (19.4) 801 (9.3) 43 (14.9) 2,657 (11.7) 288 (19.7) Exercise, n (%) Never 866 (9.1) 211 (13.5) 526 (8.5) 28 (14.6) 1,486 (9.0) 148 (14.0),1 time/week 1,248 (13.1) 233 (14.9) 789 (12.7) 24 (12.5) 2,127 (12.9) 170 (16.0) 1 2 times/week 2,663 (27.9) 377 (24.2) 1,810 (29.2) 41 (21.4) 4,645 (28.2) 248 (23.4) 3 5 times/week 2,708 (28.4) 334 (21.4) 1,529 (24.6) 40 (20.8) 4,379 (26.6) 238 (22.5) Daily 2,064 (21.6) 406 (26.0) 1,552 (25.0) 59 (30.7) 3,830 (23.3) 256 (24.2) Albuminuria, n (%) Microalbuminuria 1,473 (11.8) 389 (17.9) 1,318 (15.4) 55 (19.2) 3,036 (13.7) 202 (14.5) Macroalbuminuria 688 (5.5) 223 (10.3) 640 (7.5) 26 (9.1) 1,462 (6.6) 119 (8.6) Antihypertensives, n (%) 2,688 (20.5) 1,016 (45.6) 3,520 (40.5) 184 (63.4) 6,967 (30.5) 450 (29.9) Statins, n (%) 1,766 (13.5) 743 (33.5) 2,747 (31.8) 124 (43.1) 5,055 (22.2) 332 (22.2) Aspirin 889 (6.9) 525 (24.0) 1,706 (20.0) 108 (37.9) 3,031 (13.5) 201 (13.5) HF, n (%) 52 (0.4) 25 (1.1) 70 (0.8) 8 (2.7) 144 (0.6) 12 (0.8) AF, n (%) 29 (0.2) 14 (0.6) 75 (0.9) 10 (3.4) 114 (0.5) 14 (0.9) IHD, n (%) 30 (0.2) 32 (1.4) 91 (1.0) 9 (3.1) 148 (0.6) 14 (0.9) Data are crude baseline values as means 6 1 SD unless otherwise indicated. BP, blood pressure; Chol-to-HDL ratio, total cholesterol to HDL ratio; IHD, ischemic heart disease. a Cohabiting as registered partners. 56% greater risk of fatal/nonfatal CVD and more than twice the risk of fatal/ nonfatal CHD (HR 2.12, 95% CI ) (Fig. 1) (maximally adjusted models). Income Inverse relationships were found between income and the end points. Compared with the highest income quintile, individuals in the two lowest income quintiles had roughly twice the risk of fatal/nonfatal CVD, fatal/nonfatal CHD, and fatal/nonfatal stroke in the minimally adjusted model. This was somewhat attenuated in the maximally adjusted model (Fig. 1). Compared with the highest income quintile, the two lowest quintiles had roughly three times as great a risk of death, diabetesrelateddeath,andcvdeathinthe minimally adjusted model. The risk of all-cause death was still twice as much in the maximally adjusted model; the risk of CV death was three times as much, and the risk of diabetes-related death was twice as much (Fig. 2). Educational Level Compared with having #9 years of education, individuals with a college/ university degree had 31%, 26%, and 45% lower risk of fatal/nonfatal CVD, fatal/nonfatal CHD, and fatal/nonfatal stroke, respectively, in the minimally adjusted model. These differences were attenuated in the maximally adjusted

5 1522 Report by the Swedish National Diabetes Register Diabetes Care Volume 38, August 2015 Table 2 Characteristics of the cohort at baseline, according to income quintile and education Income quintiles (1 = lowest, 5 = highest) Educational attainment Q1 Q2 Q3 Q4 Q5 #9 years years College/university Individuals, n 5,795 4,805 4,799 4,707 4,814 4,052 13,133 7,549 Males 2,583 (44.6) 1,999 (41.6) 2,275 (47.4) 2,913 (61.9) 3,633 (75.5) 2,272 (56.1) 7,306 (55.6) 3,735 (49.5) Age (years) (16.35) (15.20) (12.42) (10.94) (10.65) (17.25) (13.39) (11.98) Onset age (years) (7.35) (7.74) (7.84) (7.71) (7.74) (7.79) (7.71) (7.64) Income, n (%) Q1 N/A N/A N/A N/A N/A 1,579 (39.0) 2,804 (21.4) 1,281 (17.0) Q2 N/A N/A N/A N/A N/A 927 (22.9) 2,770 (21.1) 1,067 (14.1) Q3 N/A N/A N/A N/A N/A 631 (15.6) 2,878 (21.9) 1,283 (17.0) Q4 N/A N/A N/A N/A N/A 565 (13.9) 2,592 (19.7) 1,548 (20.5) Q5 N/A N/A N/A N/A N/A 350 (8.6) 2,089 (15.9) 2,370 (31.4) Education, n (%) #9 years 1,579 (27.9) 927 (19.5) 631 (13.2) 565 (12.0) 350 (7.3) N/A N/A N/A years 2,804 (49.5) 2,770 (58.1) 2,878 (60.1) 2,592 (55.1) 2,089 (43.4) N/A N/A N/A College/university 1,281 (22.6) 1,067 (22.4) 1,283 (26.8) 1,548 (32.9) 2,370 (49.3) N/A N/A N/A Marital status, n (%) Single 4,036 (69.6) 2,759 (57.4) 2,604 (54.3) 2,350 (49.9) 1,811 (37.6) 2,037 (50.3) 7,507 (57.2) 3,877 (51.4) Divorced 265 (4.6) 545 (11.3) 487 (10.1) 471 (10.0) 498 (10.3) 483 (11.9) 1,210 (9.2) 567 (7.5) Married/cohabiting 1,430 (24.7) 1,417 (29.5) 1,669 (34.8) 1,844 (39.2) 2,440 (50.7) 1,415 (34.9) 4,292 (32.7) 3,055 (40.5) Widowed 64 (1.1) 84 (1.7) 39 (0.8) 42 (0.9) 65 (1.4) 117 (2.9) 124 (0.9) 50 (0.7) Immigrant, n (%) 553 (9.5) 314 (6.5) 294 (6.1) 217 (4.6) 177 (3.7) 345 (8.5) 667 (5.1) 469 (6.2) CSII, n (%) 764 (15.4) 553 (13.2) 633 (14.9) 620 (14.6) 628 (14.6) 324 (9.2) 1,689 (14.5) 1,173 (17.5) HbA1c (mmol/mol) (16.76) (15.40) (14.56) (13.33) (12.38) (15.72) (14.91) (13.07) egfr (ml/min) (32.35) (28.83) (25.94) (23.86) (24.18) (31.60) (27.09) (24.51) Systolic BP (mmhg) (16.56) (17.07) (15.11) (15.15) (14.70) (17.68) (15.72) (14.58) Chol-to-HDL ratio 3.16 (1.09) 3.12 (1.04) 3.08 (0.98) 3.13 (1.09) 3.09 (0.94) 3.23 (1.09) 3.17 (1.04) 2.97 (0.95) BMI (kg/m 2 ) (4.73) (4.72) (4.34) (4.00) (3.59) (4.72) (4.45) (3.75) Smoker, n (%) 772 (14.3) 734 (15.8) 602 (12.9) 515 (11.1) 320 (6.7) 833 (21.6) 1,663 (13.1) 425 (5.8) Exercise, n (%) Never 446 (11.3) 362 (10.9) 290 (8.7) 286 (8.4) 247 (7.0) 354 (12.8) 910 (9.8) 351 (6.6),1 time/week 505 (12.8) 447 (13.5) 438 (13.1) 437 (12.9) 467 (13.3) 404 (14.6) 1,247 (13.4) 628 (11.8) 1 2 times/week 966 (24.5) 858 (25.9) 950 (28.4) 980 (28.9) 1,137 (32.4) 684 (24.6) 2,560 (27.6) 1,625 (30.4) 3 5 times/week 1,056 (26.8) 814 (24.6) 892 (26.7) 889 (26.2) 960 (27.3) 620 (22.3) 2,363 (25.5) 1,592 (29.8) Daily 972 (24.6) 833 (25.1) 772 (23.1) 801 (23.6) 703 (20.0) 713 (25.7) 2,204 (23.7) 1,143 (21.4) Albuminuria, n (%) Microalbuminuria 598 (11.7) 684 (15.1) 671 (14.7) 647 (14.2) 635 (13.5) 679 (18.3) 1,754 (14.2) 787 (10.8) Macroalbuminuria 268 (5.2) 438 (9.7) 316 (6.9) 286 (6.3) 269 (5.7) 336 (9.1) 922 (7.5) 312 (4.3) Antihypertensives, n (%) 1,273 (23.1) 1,669 (35.6) 1,498 (31.8) 1,420 (30.7) 1,548 (32.5) 1,592 (40.4) 3,948 (30.9) 1,844 (24.9) Statins, n (%) 907 (16.5) 1,165 (24.9) 1,072 (22.9) 1,036 (22.4) 1,200 (25.3) 1,207 (30.7) 2,826 (22.2) 1,332 (18.1) Continued on p. 1523

6 care.diabetesjournals.org Rawshani and Associates 1523 Table 2 Continued Income quintiles (1 = lowest, 5 = highest) Educational attainment Q1 Q2 Q3 Q4 Q5 #9 years years College/university Aspirin, n (%) 589 (10.8) 742 (16.0) 654 (14.2) 572 (12.5) 671 (14.4) 804 (20.6) 1,660 (13.1) 752 (10.4) HF, n (%) 53 (0.9) 52 (1.1) 22 (0.5) 12 (0.3) 16 (0.3) 53 (1.3) 80 (0.6) 22 (0.3) AF, n (%) 27 (0.5) 40 (0.8) 16 (0.3) 16 (0.3) 29 (0.6) 39 (1.0) 59 (0.4) 28 (0.4) IHD, n (%) 47 (0.8) 55 (1.1) 27 (0.6) 14 (0.3) 19 (0.4) 48 (1.2) 89 (0.7) 23 (0.3) Data are crude baseline values as means 6 1 SD unless otherwise indicated. BP, blood pressure; Chol-to-HDL ratio, total cholesterol to HDL ratio. model and remained statistically significant only for fatal/nonfatal stroke (HR 0.55, 95% CI ) (Fig. 1). A similar trend was noted for those having years of education (Fig. 1). Likewise, for all-cause death, CV death, and diabetes death, a college/ university degree was protective in the minimally adjusted model, but the effect was invalidated in the maximally adjusted model (Fig. 2). Having years of education was associated with 48% higher risk of CV death compared with those having #9 years (Fig. 2). Immigrant Status The point estimates in all models indicated that immigrants had 10 40% lower risk of the outcomes compared with native Swedes (Figs. 1 and 2). This was statistically significant (in the maximally adjusted model) for fatal/nonfatal CVD, all-cause death, and diabetesrelated death. Sex Compared with women, males had 20 50% higher risk of all outcomes in the minimally adjusted models. This remained statistically significant in the maximally adjusted models for all-cause death, CV death, and diabetes-related death, with the following HRs (males vs. females): 1.44 (95% CI ), 1.63 (95% CI ), and 1.29 (95% CI ), respectively. Refer to Supplementary Table 4 for P values as well as HRs for fatal CVD and fatal/nonfatal acute myocardial infarction. CONCLUSIONS In this nationwide study of 24,947 patients with type 1 diabetes, we showed that low SES is a powerful predictor of CV morbidity and mortality in type 1 diabetes. To the best of our knowledge, this is the first study to establish these relationships. The effect of SES was striking despite rigorous adjustments for risk factors and confounders. Individuals in the two lowest income quintiles had two to three times higher risk of CV events and death than those in the highest income quintile. Compared with low educational level, having high education was associated with ;30% lower risk of stroke. Compared with being single, individuals who were married/cohabiting had.50% lower risk of death, CV death, and diabetes-related death. Immigrants had 20 40% lower risk of fatal/nonfatal CVD, all-cause death, and diabetes-related death. Additionally, we show that males had 44%, 63%, and 29% higher risk of all-cause death, CV death, and diabetes-related death, respectively. Despite rigorous adjustments for covariates and equitable access to health care at a negligible cost (20,21), SES and sex were robust predictors of CVD disease and mortality in type 1 diabetes; their effect was comparable with that of smoking, which represented an HR of 1.56 (95% CI ) for all-cause death. The fact that the excess risk was not mediated by known risk factors does not imply that risk factor control is less important. On the contrary, stringent risk factor control might be crucial in reducing morbidity and mortality among underprivileged groups, and clinicians should probably aim for rigorous risk factor control for socioeconomically vulnerable individuals with type 1 diabetes. The final solution to these disparities is, however, unlikely to emerge from conventional risk factor control. More individualized management and allocation of resources for clinics and clinicians are important measures, but they will not eliminate the gaps either. These socioeconomic disparities can only be overcome with health policy and societal reforms. Previous studies have shown that SES is associated with glycemic control and risk factors in type 1 diabetes (22 27), but very few studies have examined how SES relates to CVD and death (7 9). These studies reported either a modest effect or no significant effect of SES or they were inadequately adjusted to allow for reliable inferences. Gnavi et al. (8) examined type 1 diabetes and educational level. Individuals with low educational level were three to four times as likely to die as those with high educational level after adjustment for age and neighborhood. Secrest and colleagues studied 318 patients with type 1 diabetes and found that low educational level was associated with higher risk of death and CV complications, but this was not significant after adjusting for confounders and risk factors (7,9). Mühlhauser et al. (28) included 3,674 patients with type 1 diabetes who had participated in an intervention study.

7 1524 Report by the Swedish National Diabetes Register Diabetes Care Volume 38, August 2015 Figure 1 Adjusted HRs for CV events among patients with type 1 diabetes. Two models were computed for each outcome. The minimally adjusted models were identical for each outcome and controlled for age, sex, immigrant status, and duration of diabetes. Fatal/nonfatal CVD was additionally adjusted for smoking, systolic blood pressure, HbA 1c, exercise level, egfr, albuminuria, total cholesterol to HDL ratio, antihypertensive medications, statins, and aspirin. Fatal/nonfatal CHD and fatal/nonfatal stroke were adjusted for the same covariates. Note that the category married includes individuals who were cohabiting (registered as partners). educ., education. The authors constructed a socioeconomic score based on educational level and/or occupation and reported that it was significantly associated with death after adjusting for nephropathy, smoking, diabetes duration, cholesterol, age, sex, and systolic blood pressure. Thus, these studies indicated that education is significantly associated with morbidity and mortality. However, our study shows that the effect of education is much weaker after controlling for income. Our study shows that men with type 1 diabetes are at greater risk of CV events and death compared with women. This should be viewed in the light of a recent meta-analysis of 26 studies, which showed higher excess risk in women compared with men. Overall, women had 40% greater excess risk of all-cause mortality, and twice the excess risk of fatal/nonfatal vascular events, comparedwithmen(29).thus,whereas the excess risk (i.e., the risk of patients with diabetes compared with the nondiabetic population) of vascular disease is higher in women with diabetes, we show that men with diabetes are still at substantially greater risk of all-cause death, CV death, and diabetes death compared with women with diabetes. Other studies are in line with our findings (10,11,13,30 32). Immigrants had lower risk of CVD and death. This contrasts with findings for type 2 diabetes, where immigrants are at higher risk of death (6,33). This might be explained by the healthy immigrant effect (34) either due to healthy behaviors before migrating to a (Western) country with less healthy behaviors or due to immigrant self-selection where healthier and stronger individuals are more likely to migrate. One-third of the immigrants came from a Nordic country, one-third from another European country, and one-third from a non-western country. Unexpectedly, income Q1 had lower HRs for fatal/nonfatal CVD, CHD, and stroke in the minimally as well as maximally adjusted models. This is difficult to explain, and we did not observe this phenomenon for all-cause death, CV death, or diabetes death. However, it suggests that individuals in the lowest income quintile appear to be protected against CVD, CHD, and stroke compared with people having slightly higher income. It is possible that individuals in Q1 receive support from the social support system that alleviates some of the stress associated with low income. It follows that more individuals in Q2 arelikelytobeemployedandexperience work-related stress. It is also possible that individuals in the lowest quintile are at such high risk that they have developed disease early (before

8 care.diabetesjournals.org Rawshani and Associates 1525 Figure 2 Adjusted HRs for death from any cause and death from specific causes among patients with type 1 diabetes. Two models were computed for each outcome. The minimally adjusted models were identical for each outcome and controlled for age, sex, immigrant status, and duration of diabetes. All-cause death and CV death were additionally adjusted for smoking, HbA 1c, exercise level, egfr, CVD, albuminuria, and HF. Diabetesrelated death was additionally adjusted for smoking status, systolic blood pressure, HbA 1c, exercise level, egfr, chronic kidney disease, and albuminuria. Note that the category married includes individuals who were cohabiting (registered as partners). educ., education. start of inclusion) and thus been ineligible for inclusion in our study. Regardless, it is clear from our analyses that income is a strong predictor of morbidity and mortality. Type 1 diabetes demands a great deal of self-care and substantial lifestyle changes, as well as personal, financial, social, and community resources. The causal mechanisms by which SES affects health in type 1 diabetes are diverse. Socioeconomic deprivation triggers a range of chronic stressors, such as unemployment, marital disruption, and financial difficulties. Long-standing socioeconomic disadvantage exhausts coping abilities and causes adverse health behaviors (35,36). Having less education might make it hard to adopt healthy behaviors, partly due to lack of knowledge about their beneficial effects. It may also aggravate attempts to put in place the control mechanisms requiredtoleadahealthylifestyle. Adoption of healthy habits and avoidance of unhealthy ones can be a neverending battle. We found that income appears to have a greater effect than education in type 1 diabetes. The reason might be the immediate opportunities generated by financial privilege: the ability to pay for fitness clubs, enroll in health programs, buy expensive produce, etc., might counteract the hazards that people with low educational levels face (37). Socioeconomically disadvantaged individuals live in communities that often fail to motivate and facilitate healthy behaviors; their neighborhoods feature abundant fast food restaurants and shops that sell cigarettes and alcohol. Lack of social support, cohesion, or positive peer pressure aggravates the situation even further (38). But these factors are modifiable through targeted interventions. To the best of our knowledge, this is the largest study to have explored the association between social factors and serious outcomes in type 1 diabetes. We evaluated extensive clinical data, including 24,947 individuals in Sweden for a mean follow-up of 6 years. We had access to detailed clinical and socioeconomic data with time-updated information. All individuals in our study had equal access to heavily subsidized health care because access to and use of health care in Sweden are extremely equitable (20,21). Insulin treatment is

9 1526 Report by the Swedish National Diabetes Register Diabetes Care Volume 38, August 2015 free of charge, and the social benefits provide almost complete economic coverage for remaining health care and medications, with fixed copays up to a ceiling. These factors are therefore unlikely to have confounded our results more than to a limited extent. We also used time-updated socioeconomic data, which allows for more accurate predictionsofses.measuresfromasingle point in time might not capture actual SES and therefore not be representative of the follow-up. This consideration is particularly important in the kind of young population that we studied (39,40). Limitations of the study deserve mention. Causal inference from observational data are always open to question. The effects associated with socioeconomic factors might be mediated by other factors that are not included in our analyses. We did, however, challenge our models by including other comorbid conditions such as psychiatric diseases and cancer as well as to include profession as a covariate, but no results changed materially. The income variables measured the individuals disposable annual income. It is possible that this variable does not capture the financial resources available to an individual, particularly not household income. To some extent, this should be adjusted for by marital status, which defined individuals who had a partner. In this nationwide study in Swedend where access to and use of health care is very equitable and diabetes care is virtually free of charge and management is well developeddlow income and low educational level were associated with two to three times as great a risk of serious CV events and death in type 1 diabetes. Being male, divorced, single, or widowed was also associated with substantially higher risk of poor outcomes. Although controlling for conventional risk factors did not eliminate these disparities, stringent risk factor control and new approaches to these challenges are warranted. Acknowledgments. The authors thank the various regional NDR coordinators, as well as contributing nurses, physicians, and patients. The authors also thank George Lappas (University of Gothenburg) for invaluable statistical advice. Funding. This study was funded by the Swedish NDR. The Swedish Association of Local Authorities and Regions funds the NDR. The Swedish Diabetes Association and the Swedish Society of Diabetology support the NDR. Duality of Interest. No potential conflicts of interest relevant to this article were reported. Author Contributions. A.Ra., A.-M.S., A.Ro., B.E., and S.G. developed the study concept and design. A.Ra. performed statistical analyses. A.Ra., A.-M.S., A.Ro., B.E., and S.G. interpreted data. A.Ra. wrote the manuscript. A.Ra., A.-M.S., A.Ro., B.E., and S.G. reviewed and edited the manuscript. A.Ra. and S.G. are the guarantors of this work and, as such, had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. References 1. Galobardes B, Shaw M, Lawlor DA, Lynch JW, Davey Smith G. Indicators of socioeconomic position (part 1). J Epidemiol Community Health 2006;60: Mackenbach JP, Cavelaars AE, Kunst AE, Groenhof F. Socioeconomic inequalities in cardiovascular disease mortality; an international study. Eur Heart J 2000;21: Sundquist K, Malmström M, Johansson S-E. Neighbourhood deprivation and incidence of coronary heart disease: a multilevel study of 2.6 million women and men in Sweden. J Epidemiol Community Health 2004;58: Kanjilal S, Gregg EW, Cheng YJ, et al. Socioeconomic status and trends in disparities in 4 majorriskfactorsforcardiovasculardisease among US adults, Arch Intern Med 2006;166: Health, United States, 2011: With Special Feature on Socioeconomic Status and Health. Hyattsville, MD, U.S. National Center for Health Statistics, Saydah SH, Imperatore G, Beckles GL. Socioeconomic status and mortality: contribution of health care access and psychological distress among U.S. adults with diagnosed diabetes. Diabetes Care 2013; 36: Secrest AM, Costacou T, Gutelius B, Miller RG, Songer TJ, Orchard TJ. Association of socioeconomic status with mortality in type 1 diabetes: the Pittsburgh epidemiology of diabetes complications study. Ann Epidemiol 2011;21: Gnavi R, Petrelli A, Demaria M, Spadea T, Carta Q, Costa G. Mortality and educational level among diabetic and non-diabetic population in the Turin Longitudinal Study: a 9-year follow-up. Int J Epidemiol 2004;33: Secrest AM, Costacou T, Gutelius B, Miller RG, Songer TJ, Orchard TJ. Associations between socioeconomic status and major complications in type 1 diabetes: the Pittsburgh epidemiology of diabetes complication (EDC) Study. Ann Epidemiol 2011;21: Soedamah-Muthu SS, Vergouwe Y, Costacou T, et al. Predicting major outcomes in type 1 diabetes: a model development and validation study. Diabetologia 2014;57: Cederholm J, Eeg-Olofsson K, Eliasson B, Zethelius B, Gudbjornsdottir S, Swedish National Diabetes Register. A new model for 5-year risk of cardiovascular disease in Type 1 diabetes; from the Swedish National Diabetes Register (NDR). Diabet Med;2011;28: Rawshani A, Landin-Olsson M, Svensson AM, et al. The incidence of diabetes among 0-34 year olds in Sweden: new data and better methods. Diabetologia 2014;57: Lind M, Bounias I, Olsson M, Gudbjörnsdottir S, Svensson A-M, Rosengren A. Glycaemic control and incidence of heart failure in 20,985 patients with type 1 diabetes: an observational study. Lancet 2011;378: Eeg-Olofsson K, Cederholm J, Nilsson PM, et al. Glycemic control and cardiovascular disease in 7,454 patients with type 1 diabetes: an observational study from the Swedish National Diabetes Register (NDR). Diabetes Care 2010; 33: Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D; Modification of Diet in Renal Disease Study Group. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999;130: Ingelsson E, Arnlöv J, Sundström J, Lind L. The validity of a diagnosis of heart failure in a hospital discharge register. Eur J Heart Fail 2005;7: Ludvigsson JF, Andersson E, Ekbom A, et al. External review and validation of the Swedish national inpatient register. BMC Public Health 2011;11: Sterne JAC, White IR, Carlin JB, et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ 2009;338:b van Buuren S. Flexible Imputation of Missing Data. Boca Raton, FL, CRC Press, 2012, p Davis K, Ballreich J. Equitable access to care how the United States ranks internationally. N Engl J Med 2014;371: Anell A. The public-private pendulum patient choice and equity in Sweden. N Engl J Med 2015;372: Hassan K, Loar R, Anderson BJ, Heptulla RA. The role of socioeconomic status, depression, quality of life, and glycemic control in type 1 diabetes mellitus. J Pediatr 2006;149: Gallegos-Macias AR, Macias SR, Kaufman E, Skipper B, Kalishman N. Relationship between glycemic control, ethnicity and socioeconomic status in Hispanic and white non-hispanic youths with type 1 diabetes mellitus. Pediatr Diabetes 2003;4: Rewers A, Chase HP, Mackenzie T, et al. Predictors of acute complications in children with type 1 diabetes. JAMA 2002;287: Nádas J, Putz Z, Fövényi J, et al. Cardiometabolic risk and educational level in adult patients with type 1 diabetes. Acta Diabetol 2009;46: Kovacs M, Charron-Prochownik D, Obrosky DS. A longitudinal study of biomedical and psychosocial predictors of multiple hospitalizations among young people with insulin-dependent diabetes mellitus. Diabet Med 1995;12: Galler A, Lindau M, Ernert A, Thalemann R, Raile K. Associations between media consumption habits, physical activity, socioeconomic status, and glycemic control in children,

10 care.diabetesjournals.org Rawshani and Associates 1527 adolescents, and young adults with type 1 diabetes. Diabetes Care 2011;34: Mühlhauser I, Overmann H, Bender R, Jörgens V, Berger M. Predictors of mortality and end-stage diabetic complications in patients with type 1 diabetes mellitus on intensified insulin therapy. Diabet Med 2000;17: Huxley RR, Peters SAE, Mishra GD, Woodward M. Risk of all-cause mortality and vascular events in women versus men with type 1 diabetes: a systematic review and meta-analysis. Lancet Diabetes Endocrinol 2015;3: Waernbaum I, Blohmé G,OstmanJ,etal. Excess mortality in incident cases of diabetes mellitus aged 15 to 34 years at diagnosis: a population-based study (DISS) in Sweden. Diabetologia 2006;49: Cederholm J, Eliasson B, Nilsson PM, Weiss L, Gudbjörnsdottir S; SteeringCommitteeoftheSwedish National Diabetes Register. Microalbuminuria and risk factors in type 1 and type 2 diabetic patients. Diabetes Res Clin Pract 2005;67: Raile K, Galler A, Hofer S, et al. Diabetic nephropathy in 27,805 children, adolescents, and adults with type 1 diabetes: effect of diabetes duration, A1C, hypertension, dyslipidemia, diabetes onset, and sex. Diabetes Care 2007; 30: Hunt BR, Whitman S, Henry CA. Ageadjusted diabetes mortality rates vary in local communities in a metropolitan area: racial and spatial disparities and correlates. Diabetes Care 2014;37: McDonald JT, Kennedy S. Insights into the healthy immigrant effect : healthstatusand health service use of immigrants to Canada. Soc Sci Med 2004;59: Meyer IH, Schwartz S, Frost DM. Social patterning of stress and coping: does disadvantaged social statuses confer more stress and fewer coping resources? Soc Sci Med 2008;67: Pampel FC, Krueger PM, Denney JT. Socioeconomic Disparities in Health Behaviors. Annu Rev Sociol 2010;36: Cutler DM, Lleras-Muney A. Understanding differences in health behaviors by education. J Health Econ 2010;29: Fujiwara T, Kawachi I. Social capital and health. A study of adult twins in the U.S. Am J Prev Med 2008;35: Pensola TH, Martikainen P. Cumulative social class and mortality from various causes of adult men. J Epidemiol Community Health 2003; 57: Smith GD, Hart C, Blane D, Gillis C, Hawthorne V. Lifetime socioeconomic position and mortality: prospective observational study. BMJ 1997;314:

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Rawshani Aidin, Rawshani Araz, Franzén S, et al. Risk factors,

More information

Glycemic Control, Renal Complications, and Current Smoking in Relation to Excess Risk of Mortality in Persons With Type 1 Diabetes

Glycemic Control, Renal Complications, and Current Smoking in Relation to Excess Risk of Mortality in Persons With Type 1 Diabetes 652901DSTXXX10.1177/1932296816652901Journal of Diabetes Science and TechnologyAhlén et al research-article2016 Special Section Glycemic Control, Renal Complications, and Current Smoking in Relation to

More information

egfr > 50 (n = 13,916)

egfr > 50 (n = 13,916) Saxagliptin and Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus and Moderate or Severe Renal Impairment: Observations from the SAVOR-TIMI 53 Trial Supplementary Table 1. Characteristics according

More information

Diabetes Mellitus: A Cardiovascular Disease

Diabetes Mellitus: A Cardiovascular Disease Diabetes Mellitus: A Cardiovascular Disease Nestoras Mathioudakis, M.D. Assistant Professor of Medicine Division of Endocrinology, Diabetes, & Metabolism September 30, 2013 1 The ABCs of cardiovascular

More information

Supplement materials:

Supplement materials: Supplement materials: Table S1: ICD-9 codes used to define prevalent comorbid conditions and incident conditions Comorbid condition ICD-9 code Hypertension 401-405 Diabetes mellitus 250.x Myocardial infarction

More information

abstract n engl j med 376;15 nejm.org April 13,

abstract n engl j med 376;15 nejm.org April 13, The new england journal of medicine established in 1812 April 13, 217 vol. 376 no. 15 Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes Aidin Rawshani, M.D., Araz Rawshani, M.D., Ph.D.,

More information

Prevention of complications: are we winning or losing the battle. Naveed Sattar Professor of Metabolic Medicine

Prevention of complications: are we winning or losing the battle. Naveed Sattar Professor of Metabolic Medicine Prevention of complications: are we winning or losing the battle Naveed Sattar Professor of Metabolic Medicine Duality of Interest Declaration Consultant or speaker for: Amgen, AstraZeneca, Boehringer

More information

SUPPLEMENTARY DATA. Supplementary Figure S1. Cohort definition flow chart.

SUPPLEMENTARY DATA. Supplementary Figure S1. Cohort definition flow chart. Supplementary Figure S1. Cohort definition flow chart. Supplementary Table S1. Baseline characteristics of study population grouped according to having developed incident CKD during the follow-up or not

More information

BMJ Open. For peer review only - Journal: BMJ Open. Manuscript ID: bmjopen

BMJ Open. For peer review only -   Journal: BMJ Open. Manuscript ID: bmjopen Aspirin treatment and risk of first incident cardiovascular diseases in patients with type diabetes: an observational study from the Swedish National Diabetes Register (NDR) Journal: BMJ Open Manuscript

More information

Blood pressure and complications in individuals with type 2 diabetes and no previous cardiovascular disease: national population based cohort study

Blood pressure and complications in individuals with type 2 diabetes and no previous cardiovascular disease: national population based cohort study OPEN ACCESS Blood pressure and complications in individuals with type 2 diabetes and no previous cardiovascular disease: national population based cohort study Samuel Adamsson Eryd, 1,2,3 Soffia Gudbjörnsdottir,

More information

Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes

Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes The new england journal of medicine Original Article Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes Aidin Rawshani, M.D., Araz Rawshani, M.D., Ph.D., Stefan Franzén,

More information

Appendix This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors.

Appendix This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors. Appendix This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors. Appendix to: Banks E, Crouch SR, Korda RJ, et al. Absolute risk of cardiovascular

More information

Supplementary Table 1. Baseline Characteristics by Quintiles of Systolic and Diastolic Blood Pressures

Supplementary Table 1. Baseline Characteristics by Quintiles of Systolic and Diastolic Blood Pressures Supplementary Data Supplementary Table 1. Baseline Characteristics by Quintiles of Systolic and Diastolic Blood Pressures Quintiles of Systolic Blood Pressure Quintiles of Diastolic Blood Pressure Q1 Q2

More information

Lucia Cea Soriano 1, Saga Johansson 2, Bergur Stefansson 2 and Luis A García Rodríguez 1*

Lucia Cea Soriano 1, Saga Johansson 2, Bergur Stefansson 2 and Luis A García Rodríguez 1* Cea Soriano et al. Cardiovascular Diabetology (2015) 14:38 DOI 10.1186/s12933-015-0204-5 CARDIO VASCULAR DIABETOLOGY ORIGINAL INVESTIGATION Open Access Cardiovascular events and all-cause mortality in

More information

Ischemic Heart and Cerebrovascular Disease. Harold E. Lebovitz, MD, FACE Kathmandu November 2010

Ischemic Heart and Cerebrovascular Disease. Harold E. Lebovitz, MD, FACE Kathmandu November 2010 Ischemic Heart and Cerebrovascular Disease Harold E. Lebovitz, MD, FACE Kathmandu November 2010 Relationships Between Diabetes and Ischemic Heart Disease Risk of Cardiovascular Disease in Different Categories

More information

ESM1 for Glucose, blood pressure and cholesterol levels and their relationships to clinical outcomes in type 2 diabetes: a retrospective cohort study

ESM1 for Glucose, blood pressure and cholesterol levels and their relationships to clinical outcomes in type 2 diabetes: a retrospective cohort study ESM1 for Glucose, blood pressure and cholesterol levels and their relationships to clinical outcomes in type 2 diabetes: a retrospective cohort study Statistical modelling details We used Cox proportional-hazards

More information

USRDS UNITED STATES RENAL DATA SYSTEM

USRDS UNITED STATES RENAL DATA SYSTEM USRDS UNITED STATES RENAL DATA SYSTEM Chapter 2: Identification and Care of Patients With CKD Over half of patients from the Medicare 5 percent sample have either a diagnosis of chronic kidney disease

More information

Glycemic Control and Excess Mortality in Type 1 Diabetes

Glycemic Control and Excess Mortality in Type 1 Diabetes The new england journal of medicine Original Article Glycemic Control and Excess Mortality in Type 1 Diabetes Marcus Lind, M.D., Ph.D., Ann Marie Svensson, Ph.D., Mikhail Kosiborod, M.D., Soffia Gudbjörnsdottir,

More information

1. Albuminuria an early sign of glomerular damage and renal disease. albuminuria

1. Albuminuria an early sign of glomerular damage and renal disease. albuminuria 1. Albuminuria an early sign of glomerular damage and renal disease albuminuria Cardio-renal continuum REGRESS Target organ damage Asymptomatic CKD New risk factors Atherosclerosis Target organ damage

More information

8/10/2012. Education level and diabetes risk: The EPIC-InterAct study AIM. Background. Case-cohort design. Int J Epidemiol 2012 (in press)

8/10/2012. Education level and diabetes risk: The EPIC-InterAct study AIM. Background. Case-cohort design. Int J Epidemiol 2012 (in press) Education level and diabetes risk: The EPIC-InterAct study 50 authors from European countries Int J Epidemiol 2012 (in press) Background Type 2 diabetes mellitus (T2DM) is one of the most common chronic

More information

Microvascular Disease in Type 1 Diabetes

Microvascular Disease in Type 1 Diabetes Microvascular Disease in Type 1 Diabetes Jay S. Skyler, MD, MACP Division of Endocrinology, Diabetes, and Metabolism and Diabetes Research Institute University of Miami Miller School of Medicine The Course

More information

Chapter 2: Identification and Care of Patients With CKD

Chapter 2: Identification and Care of Patients With CKD Chapter 2: Identification and Care of Patients With Over half of patients from the Medicare 5% sample (restricted to age 65 and older) have a diagnosis of chronic kidney disease (), cardiovascular disease,

More information

Blood Pressure Targets in Diabetes

Blood Pressure Targets in Diabetes Stockholm, 29 th August 2010 ESC Meeting Blood Pressure Targets in Diabetes Peter M Nilsson, MD, PhD Department of Clinical Sciences University Hospital, Malmö Sweden Studies on BP in DM2 ADVANCE RCT (Lancet

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE QUALITY AND OUTCOMES FRAMEWORK (QOF) INDICATOR DEVELOPMENT PROGRAMME Briefing paper QOF indicator area: Primary prevention of CVD Potential output:

More information

Excess Mortality among Persons with Type 2 Diabetes

Excess Mortality among Persons with Type 2 Diabetes The new england journal of medicine Original Article Excess Mortality among Persons with Type 2 Diabetes Mauro Tancredi, M.D., Annika Rosengren, M.D., Ann Marie Svensson, Ph.D., Mikhail Kosiborod, M.D.,

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Weintraub WS, Grau-Sepulveda MV, Weiss JM, et al. Comparative

More information

4/7/ The stats on heart disease. + Deaths & Age-Adjusted Death Rates for

4/7/ The stats on heart disease. + Deaths & Age-Adjusted Death Rates for + Update on Lipid Management Stacey Gardiner, MD Assistant Professor Division of Cardiovascular Medicine Medical College of Wisconsin + The stats on heart disease Over the past 10 years for which statistics

More information

American Academy of Insurance Medicine

American Academy of Insurance Medicine American Academy of Insurance Medicine October 2012 Dr. Alison Moy Liberty Mutual Dr. John Kirkpatrick Thrivent Financial for Lutherans 1 59 year old male, diagnosed with T2DM six months ago Nonsmoker

More information

Chapter 1: CKD in the General Population

Chapter 1: CKD in the General Population Chapter 1: CKD in the General Population Overall prevalence of CKD (Stages 1-5) in the U.S. adult general population was 14.8% in 2011-2014. CKD Stage 3 is the most prevalent (NHANES: Figure 1.2 and Table

More information

LEADER Liraglutide and cardiovascular outcomes in type 2 diabetes

LEADER Liraglutide and cardiovascular outcomes in type 2 diabetes LEADER Liraglutide and cardiovascular outcomes in type 2 diabetes Presented at DSBS seminar on mediation analysis August 18 th Søren Rasmussen, Novo Nordisk. LEADER CV outcome study To determine the effect

More information

Treatment disparities for patients diagnosed with metastatic bladder cancer in California

Treatment disparities for patients diagnosed with metastatic bladder cancer in California Treatment disparities for patients diagnosed with metastatic bladder cancer in California Rosemary D. Cress, Dr. PH, Amy Klapheke, MPH Public Health Institute Cancer Registry of Greater California Introduction

More information

ARIC Manuscript Proposal # PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority:

ARIC Manuscript Proposal # PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority: ARIC Manuscript Proposal # 1475 PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority: 1.a. Full Title: Hypertension, left ventricular hypertrophy, and risk of incident hospitalized

More information

ISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP OVERVIEW

ISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP OVERVIEW ISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP OVERVIEW 2014 PQRS OPTIONS F MEASURES GROUPS: 2014 PQRS MEASURES IN ISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP: #204. Ischemic Vascular Disease (IVD):

More information

Blood Pressure and Complications in Individuals with Type 2 Diabetes and No Previous Cardiovascular Disease. ID BMJ

Blood Pressure and Complications in Individuals with Type 2 Diabetes and No Previous Cardiovascular Disease. ID BMJ 1 Blood Pressure and Complications in Individuals with Type 2 Diabetes and No Previous Cardiovascular Disease. ID BMJ 2016.033440 Dear Editor, Editorial Committee and Reviewers Thank you for your appreciation

More information

Glycemic Control and Cardiovascular Disease in 7,454 Patients With Type 1 Diabetes

Glycemic Control and Cardiovascular Disease in 7,454 Patients With Type 1 Diabetes Cardiovascular and Metabolic Risk O R I G I N A L A R T I C L E Glycemic Control and Cardiovascular Disease in 7,454 Patients With Type 1 Diabetes An observational study from the Swedish National Diabetes

More information

Northwestern University Feinberg School of Medicine Calculating the CVD Risk Score: Which Tool for Which Patient?

Northwestern University Feinberg School of Medicine Calculating the CVD Risk Score: Which Tool for Which Patient? Northwestern University Feinberg School of Medicine Calculating the CVD Risk Score: Which Tool for Which Patient? Donald M. Lloyd-Jones, MD, ScM, FACC, FAHA Senior Associate Dean Chair, Department of Preventive

More information

Update on CVD and Microvascular Complications in T2D

Update on CVD and Microvascular Complications in T2D Update on CVD and Microvascular Complications in T2D Jay S. Skyler, MD, MACP Division of Endocrinology, Diabetes, and Metabolism and Diabetes Research Institute University of Miami Miller School of Medicine

More information

Kidney and heart: dangerous liaisons. Luis M. RUILOPE (Madrid, Spain)

Kidney and heart: dangerous liaisons. Luis M. RUILOPE (Madrid, Spain) Kidney and heart: dangerous liaisons Luis M. RUILOPE (Madrid, Spain) Type 2 diabetes and renal disease: impact on cardiovascular outcomes The "heavyweights" of modifiable CVD risk factors Hypertension

More information

Schöttker et al. BMC Medicine (2016) 14:26 DOI /s

Schöttker et al. BMC Medicine (2016) 14:26 DOI /s Schöttker et al. BMC Medicine (2016) 14:26 DOI 10.1186/s12916-016-0570-1 RESEARCH ARTICLE HbA 1c levels in non-diabetic older adults No J-shaped associations with primary cardiovascular events, cardiovascular

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Kavousi M, Leening MJG, Nanchen D, et al. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines

More information

Chapter 2: Identification and Care of Patients With Chronic Kidney Disease

Chapter 2: Identification and Care of Patients With Chronic Kidney Disease Chapter 2: Identification and Care of Patients With Chronic Kidney Disease Introduction The examination of care in patients with chronic kidney disease (CKD) is a significant challenge, as most large datasets

More information

Felix Vallotton Ball (1899) LDL-C management in Asian diabetes: moderate vs. high intensity statin --- a lesson from EMPATHY study

Felix Vallotton Ball (1899) LDL-C management in Asian diabetes: moderate vs. high intensity statin --- a lesson from EMPATHY study Felix Vallotton Ball (1899) LDL-C management in Asian diabetes: moderate vs. high intensity statin --- a lesson from EMPATHY study Conflict of interest disclosure None Committee of Scientific Affairs Committee

More information

Disclosures. Diabetes and Cardiovascular Risk Management. Learning Objectives. Atherosclerotic Cardiovascular Disease

Disclosures. Diabetes and Cardiovascular Risk Management. Learning Objectives. Atherosclerotic Cardiovascular Disease Disclosures Diabetes and Cardiovascular Risk Management Tony Hampton, MD, MBA Medical Director Advocate Aurora Operating System Advocate Aurora Healthcare Downers Grove, IL No conflicts or disclosures

More information

Zhao Y Y et al. Ann Intern Med 2012;156:

Zhao Y Y et al. Ann Intern Med 2012;156: Zhao Y Y et al. Ann Intern Med 2012;156:560-569 Introduction Fibrates are commonly prescribed to treat dyslipidemia An increase in serum creatinine level after use has been observed in randomized, placebocontrolled

More information

Chapter 2: Identification and Care of Patients With CKD

Chapter 2: Identification and Care of Patients With CKD Chapter 2: Identification and Care of Patients With CKD Over half of patients in the Medicare 5% sample (aged 65 and older) had at least one of three diagnosed chronic conditions chronic kidney disease

More information

Table S1. Read and ICD 10 diagnosis codes for polymyalgia rheumatica and giant cell arteritis

Table S1. Read and ICD 10 diagnosis codes for polymyalgia rheumatica and giant cell arteritis SUPPLEMENTARY MATERIAL TEXT Text S1. Multiple imputation TABLES Table S1. Read and ICD 10 diagnosis codes for polymyalgia rheumatica and giant cell arteritis Table S2. List of drugs included as immunosuppressant

More information

Diabetic Dyslipidemia

Diabetic Dyslipidemia Diabetic Dyslipidemia Dr R V S N Sarma, M.D., (Internal Medicine), M.Sc., (Canada), Consultant Physician Cardiovascular disease (CVD) is a significant cause of illness, disability, and death among individuals

More information

Why Do We Treat Obesity? Epidemiology

Why Do We Treat Obesity? Epidemiology Why Do We Treat Obesity? Epidemiology Epidemiology of Obesity U.S. Epidemic 2 More than Two Thirds of US Adults Are Overweight or Obese 87.5 NHANES Data US Adults Age 2 Years (Crude Estimate) Population

More information

Diabetes and Cardiovascular Risk Management Denise M. Kolanczyk, PharmD, BCPS-AQ Cardiology

Diabetes and Cardiovascular Risk Management Denise M. Kolanczyk, PharmD, BCPS-AQ Cardiology Diabetes and Cardiovascular Risk Management Denise M. Kolanczyk, PharmD, BCPS-AQ Cardiology Disclosures In compliance with the accrediting board policies, the American Diabetes Association requires the

More information

Diabetic Nephropathy. Objectives:

Diabetic Nephropathy. Objectives: There are, in truth, no specialties in medicine, since to know fully many of the most important diseases a man must be familiar with their manifestations in many organs. William Osler 1894. Objectives:

More information

Scottish Diabetes Survey

Scottish Diabetes Survey Scottish Diabetes Survey 2008 Scottish Diabetes Survey Monitoring Group Foreword The information presented in this 2008 Scottish Diabetes Survey demonstrates a large body of work carried out by health

More information

Antihypertensive Trial Design ALLHAT

Antihypertensive Trial Design ALLHAT 1 U.S. Department of Health and Human Services Major Outcomes in High Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic National Institutes

More information

Dyslipidemia in women: Who should be treated and how?

Dyslipidemia in women: Who should be treated and how? Dyslipidemia in women: Who should be treated and how? Lale Tokgozoglu, MD, FACC, FESC Professor of Cardiology Hacettepe University Faculty of Medicine Ankara, Turkey. Cause of Death in Women: European

More information

CVD risk assessment using risk scores in primary and secondary prevention

CVD risk assessment using risk scores in primary and secondary prevention CVD risk assessment using risk scores in primary and secondary prevention Raul D. Santos MD, PhD Heart Institute-InCor University of Sao Paulo Brazil Disclosure Honoraria for consulting and speaker activities

More information

SUPPLEMENTAL MATERIAL

SUPPLEMENTAL MATERIAL SUPPLEMENTAL MATERIAL 1 Supplemental Table 1. ICD codes Diagnoses, surgical procedures, and pharmacotherapy used for defining the study population, comorbidity, and outcomes Study population Atrial fibrillation

More information

Insulin pump therapy, multiple daily injections, and cardiovascular mortality in people with type 1 diabetes: observational study

Insulin pump therapy, multiple daily injections, and cardiovascular mortality in people with type 1 diabetes: observational study open access Insulin pump therapy, multiple daily injections, and cardiovascular mortality in 18 168 people with type 1 diabetes: observational study Isabelle Steineck, 1 Jan Cederholm, 2 Björn Eliasson,

More information

Cardiovascular Complications of Diabetes

Cardiovascular Complications of Diabetes VBWG Cardiovascular Complications of Diabetes Nicola Abate, M.D., F.N.L.A. Professor and Chief Division of Endocrinology and Metabolism The University of Texas Medical Branch Galveston, Texas Coronary

More information

The Whitehall II study originally comprised 10,308 (3413 women) individuals who, at

The Whitehall II study originally comprised 10,308 (3413 women) individuals who, at Supplementary notes on Methods The study originally comprised 10,308 (3413 women) individuals who, at recruitment in 1985/8, were London-based government employees (civil servants) aged 35 to 55 years.

More information

Tennessee Department of Health in collaboration with Tennessee State University and University of Tennessee Health Science Center

Tennessee Department of Health in collaboration with Tennessee State University and University of Tennessee Health Science Center Tennessee Department of Health in collaboration with Tennessee State University and University of Tennessee Health Science Center 2006 Tennessee Department of Health 2006 ACKNOWLEDGEMENTS CONTRIBUTING

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Inohara T, Xian Y, Liang L, et al. Association of intracerebral hemorrhage among patients taking non vitamin K antagonist vs vitamin K antagonist oral anticoagulants with in-hospital

More information

Primary Prevention of Stroke

Primary Prevention of Stroke Primary Prevention of Stroke Dr Chris Ellis Cardiologist Green Lane CVS Service, Auckland City Hospital & Auckland Heart Group, Mercy Hospital, Auckland 67 Pages Long, 735 References 29 Sub-Headings for

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Wanner C, Inzucchi SE, Lachin JM, et al. Empagliflozin and

More information

Complications of Diabetes: Screening and Prevention

Complications of Diabetes: Screening and Prevention Complications of Diabetes: Screening and Prevention Dr Steve Cleland Consultant Physician GGH and QEUH Diabetes Staff Education Course June 17 Diabetic Complications Microvascular: Retinopathy Nephropathy

More information

This clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data.

This clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data. abcd Clinical Study Synopsis for Public Disclosure This clinical study synopsis is provided in line with s Policy on Transparency and Publication of Clinical Study Data. The synopsis which is part of the

More information

The University of Mississippi School of Pharmacy

The University of Mississippi School of Pharmacy LONG TERM PERSISTENCE WITH ACEI/ARB THERAPY AFTER ACUTE MYOCARDIAL INFARCTION: AN ANALYSIS OF THE 2006-2007 MEDICARE 5% NATIONAL SAMPLE DATA Lokhandwala T. MS, Yang Y. PhD, Thumula V. MS, Bentley J.P.

More information

Why is Earlier and More Aggressive Treatment of T2 Diabetes Better?

Why is Earlier and More Aggressive Treatment of T2 Diabetes Better? Blood glucose (mmol/l) Why is Earlier and More Aggressive Treatment of T2 Diabetes Better? Disclosures Dr Kennedy has provided CME, been on advisory boards or received travel or conference support from:

More information

Biases in clinical research. Seungho Ryu, MD, PhD Kanguk Samsung Hospital, Sungkyunkwan University

Biases in clinical research. Seungho Ryu, MD, PhD Kanguk Samsung Hospital, Sungkyunkwan University Biases in clinical research Seungho Ryu, MD, PhD Kanguk Samsung Hospital, Sungkyunkwan University Learning objectives Describe the threats to causal inferences in clinical studies Understand the role of

More information

Table S1: Diagnosis and Procedure Codes Used to Ascertain Incident Hip Fracture

Table S1: Diagnosis and Procedure Codes Used to Ascertain Incident Hip Fracture Technical Appendix Table S1: Diagnosis and Procedure Codes Used to Ascertain Incident Hip Fracture and Associated Surgical Treatment ICD 9 Code Descriptions Hip Fracture 820.XX Fracture neck of femur 821.XX

More information

Supplemental Table 1. Standardized Serum Creatinine Measurements. Supplemental Table 3. Sensitivity Analyses with Additional Mortality Outcomes.

Supplemental Table 1. Standardized Serum Creatinine Measurements. Supplemental Table 3. Sensitivity Analyses with Additional Mortality Outcomes. SUPPLEMENTAL MATERIAL Supplemental Table 1. Standardized Serum Creatinine Measurements Supplemental Table 2. List of ICD 9 and ICD 10 Billing Codes Supplemental Table 3. Sensitivity Analyses with Additional

More information

Supplementary appendix

Supplementary appendix Supplementary appendix This appendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Shah AD, Langenberg C, Rapsomaniki E, et al.

More information

9/29/2015. Primary Prevention of Heart Disease: Objectives. Objectives. What works? What doesn t?

9/29/2015. Primary Prevention of Heart Disease: Objectives. Objectives. What works? What doesn t? Primary Prevention of Heart Disease: What works? What doesn t? Samia Mora, MD, MHS Associate Professor, Harvard Medical School Associate Physician, Brigham and Women s Hospital October 2, 2015 Financial

More information

Guidelines on cardiovascular risk assessment and management

Guidelines on cardiovascular risk assessment and management European Heart Journal Supplements (2005) 7 (Supplement L), L5 L10 doi:10.1093/eurheartj/sui079 Guidelines on cardiovascular risk assessment and management David A. Wood 1,2 * 1 Cardiovascular Medicine

More information

Sex differences in risk factors for myocardial infarction: cohort study of UK Biobank participants

Sex differences in risk factors for myocardial infarction: cohort study of UK Biobank participants Sex differences in risk factors for myocardial infarction: cohort study of UK Biobank participants Elizabeth R C Millett, 1 Sanne A E Peters, 1,2 Mark Woodward 1,3,4 1 The George Institute for Global Health,

More information

Diabetes Guidelines in View of Recent Clinical Trials Are They Still Applicable?

Diabetes Guidelines in View of Recent Clinical Trials Are They Still Applicable? Diabetes Guidelines in View of Recent Clinical Trials Are They Still Applicable? Jay S. Skyler, MD, MACP Division of Endocrinology, Diabetes, and Metabolism and Diabetes Research Institute University of

More information

Lee Nedkoff a. Matthew Knuiman a. Joseph Hung b. Tom G Briffa a. Affiliations. School of Population Health, The University of Western Australia

Lee Nedkoff a. Matthew Knuiman a. Joseph Hung b. Tom G Briffa a. Affiliations. School of Population Health, The University of Western Australia Long-term all-cause and cardiovascular mortality following incident myocardial infarction in men and women with and without diabetes: temporal trends from 1998-2009 Lee Nedkoff a Matthew Knuiman a Joseph

More information

Standards of Medical Care in Diabetes 2016

Standards of Medical Care in Diabetes 2016 Standards of Medical Care in Diabetes 2016 Care Delivery Systems 33-49% of patients still do not meet targets for A1C, blood pressure, or lipids. 14% meet targets for all A1C, BP, lipids, and nonsmoking

More information

Morbidity & Mortality from Chronic Kidney Disease

Morbidity & Mortality from Chronic Kidney Disease Morbidity & Mortality from Chronic Kidney Disease Dr. Lam Man-Fai ( 林萬斐醫生 ) Honorary Clinical Assistant Professor MBBS, MRCP, FHKCP, FHKAM, PDipID (HK), FRCP (Edin, Glasg) Hong Kong Renal Registry Report

More information

John J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam

John J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam Latest Insights from the JUPITER Study John J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam Inflammation, hscrp, and Vascular Prevention

More information

Συμπεράσματα από τις νέες μελέτες για την αρτηριακή υπέρταση (SPRINT,PATHAY 2,HOPE 3)

Συμπεράσματα από τις νέες μελέτες για την αρτηριακή υπέρταση (SPRINT,PATHAY 2,HOPE 3) Συμπεράσματα από τις νέες μελέτες για την αρτηριακή υπέρταση (SPRINT,PATHAY 2,HOPE 3) Χάρης Γράσσος MD,FESC,PhD,EHS Διευθυντής Καρδιολόγος Γ.Ν.Α ΚΑΤ Visiting Professor University of Bolton U.K New England

More information

Diabetes and Kidney Disease. Kris Bentley Renal Nurse practitioner 2018

Diabetes and Kidney Disease. Kris Bentley Renal Nurse practitioner 2018 Diabetes and Kidney Disease Kris Bentley Renal Nurse practitioner 2018 Aims Develop an understanding of Chronic Kidney Disease Understand how diabetes impacts on your kidneys Be able to recognise the risk

More information

Range of Risk Factor Levels/ Control, Mortality and Cardiovascular. Outcomes in Type 1 Diabetes

Range of Risk Factor Levels/ Control, Mortality and Cardiovascular. Outcomes in Type 1 Diabetes Range of Risk Factor Levels/ Control, Mortality and Cardiovascular Outcomes in Type 1 Diabetes Running Title: Rawshani et al.; Risk Factor Control, Mortality and CVD in T1DM Aidin Rawshani, MD 1,2 ; Araz

More information

Hypertension targets: sorting out the confusion. Brian Rayner, Division of Nephrology and Hypertension, University of Cape Town

Hypertension targets: sorting out the confusion. Brian Rayner, Division of Nephrology and Hypertension, University of Cape Town Hypertension targets: sorting out the confusion Brian Rayner, Division of Nephrology and Hypertension, University of Cape Town Historical Perspective The most famous casualty of this approach was the

More information

Elevation of Serum Creatinine: When to Screen, When to Refer. Bruce F. Culleton, MD, FRCPC; and Jolanta Karpinski, MD, FRCPC

Elevation of Serum Creatinine: When to Screen, When to Refer. Bruce F. Culleton, MD, FRCPC; and Jolanta Karpinski, MD, FRCPC Elevation of Serum Creatinine: When to Screen, When to Refer Bruce F. Culleton, MD, FRCPC; and Jolanta Karpinski, MD, FRCPC Presented at the University of Calgary s CME and Professional Development 2006-2007

More information

Chronic kidney disease (CKD) has received

Chronic kidney disease (CKD) has received Participant Follow-up in the Kidney Early Evaluation Program (KEEP) After Initial Detection Allan J. Collins, MD, FACP, 1,2 Suying Li, PhD, 1 Shu-Cheng Chen, MS, 1 and Joseph A. Vassalotti, MD 3,4 Background:

More information

Ann Rheum Dis 2017;76: doi: /annrheumdis Lin, Wan-Ting 2018/05/161

Ann Rheum Dis 2017;76: doi: /annrheumdis Lin, Wan-Ting 2018/05/161 Ann Rheum Dis 2017;76:1642 1647. doi:10.1136/annrheumdis-2016-211066 Lin, Wan-Ting 2018/05/161 Introduction We and others have previously demonstrated an increased risk of acute coronary syndrome (ACS)

More information

Ann-Marie Svensson 1,2, Mervete Miftaraj 1, Stefan Franzén 1 and Björn Eliasson 2,3*

Ann-Marie Svensson 1,2, Mervete Miftaraj 1, Stefan Franzén 1 and Björn Eliasson 2,3* Svensson et al. Clinical Diabetes and Endocrinology (2017) 3:5 DOI 10.1186/s40842-017-0043-2 RESEARCH ARTICLE Clinical effects, cardiovascular and renal outcomes associated with rapid-acting insulin analogs

More information

CVD Prevention, Who to Consider

CVD Prevention, Who to Consider Continuing Professional Development 3rd annual McGill CME Cruise September 20 27, 2015 CVD Prevention, Who to Consider Dr. Guy Tremblay Excellence in Health Care and Lifelong Learning Global CV risk assessment..

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Bucholz EM, Butala NM, Ma S, Normand S-LT, Krumholz HM. Life

More information

A nationwide population-based study. Pai-Feng Hsu M.D. Shao-Yuan Chuang PhD

A nationwide population-based study. Pai-Feng Hsu M.D. Shao-Yuan Chuang PhD The Association of Clinical Symptomatic Hypoglycemia with Cardiovascular Events and Total Death in Type 2 Diabetes Mellitus A nationwide population-based study Pai-Feng Hsu M.D. Shao-Yuan Chuang PhD Taipei

More information

The Clinical Unmet need in the patient with Diabetes and ACS

The Clinical Unmet need in the patient with Diabetes and ACS The Clinical Unmet need in the patient with Diabetes and ACS Professor Kausik Ray (UK) BSc(hons), MBChB, MD, MPhil, FRCP (lon), FRCP (ed), FACC, FESC, FAHA Diabetes is a global public health challenge

More information

Recent trends in life expectancy for people with type 1 diabetes in Sweden

Recent trends in life expectancy for people with type 1 diabetes in Sweden Diabetologia (216) 59:1167 1176 DOI 1.17/s125-16-3914-7 ARTICLE Recent trends in life expectancy for people with type 1 diabetes in Sweden Dennis Petrie 1 & Tom W. C. Lung 1,2 & Aidin Rawshani 3 & Andrew

More information

Chapter 2: Identification and Care of Patients with CKD

Chapter 2: Identification and Care of Patients with CKD Chapter 2: Identification and Care of Patients with CKD Over half of patients in the Medicare 5% sample (aged 65 and older) had at least one of three diagnosed chronic conditions chronic kidney disease

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Li S, Chiuve SE, Flint A, et al. Better diet quality and decreased mortality among myocardial infarction survivors. JAMA Intern Med. Published online September 2, 2013. doi:10.1001/jamainternmed.2013.9768.

More information

ESC GUIDELINES ON DIABETES AND CARDIOVASCULAR DISEASES

ESC GUIDELINES ON DIABETES AND CARDIOVASCULAR DISEASES ESC GUIDELINES ON DIABETES AND CARDIOVASCULAR DISEASES Pr. Michel KOMAJDA Institute of Cardiology - IHU ICAN Pitie Salpetriere Hospital - University Pierre and Marie Curie, Paris (France) DEFINITION A

More information

The Heart of a Woman. Karen E. Friday, M.D. Associate Professor of Medicine Section of Endocrinology Louisiana State University School of Medicine

The Heart of a Woman. Karen E. Friday, M.D. Associate Professor of Medicine Section of Endocrinology Louisiana State University School of Medicine The Heart of a Woman Karen E. Friday, M.D. Associate Professor of Medicine Section of Endocrinology Louisiana State University School of Medicine American Heart Association Women, Heart Disease and Stroke

More information

Discontinuation and restarting in patients on statin treatment: prospective open cohort study using a primary care database

Discontinuation and restarting in patients on statin treatment: prospective open cohort study using a primary care database open access Discontinuation and restarting in patients on statin treatment: prospective open cohort study using a primary care database Yana Vinogradova, 1 Carol Coupland, 1 Peter Brindle, 2,3 Julia Hippisley-Cox

More information

Impaired Chronotropic Response to Exercise Stress Testing in Patients with Diabetes Predicts Future Cardiovascular Events

Impaired Chronotropic Response to Exercise Stress Testing in Patients with Diabetes Predicts Future Cardiovascular Events Diabetes Care Publish Ahead of Print, published online May 28, 2008 Chronotropic response in patients with diabetes Impaired Chronotropic Response to Exercise Stress Testing in Patients with Diabetes Predicts

More information

Blood Pressure LIMBO How Low To Go?

Blood Pressure LIMBO How Low To Go? Blood Pressure LIMBO How Low To Go? Joseph L. Kummer, MD, FACC Bryan Heart Spring Conference April 21 st, 2018 Hypertension Epidemiology Over a billion people have hypertension Major cause of morbidity

More information

Combined effects of systolic blood pressure and serum cholesterol on cardiovascular mortality in young (<55 years) men and women

Combined effects of systolic blood pressure and serum cholesterol on cardiovascular mortality in young (<55 years) men and women European Heart Journal (2002) 23, 528 535 doi:10.1053/euhj.2001.2888, available online at http://www.idealibrary.com on Combined effects of systolic blood pressure and serum cholesterol on cardiovascular

More information

A: Epidemiology update. Evidence that LDL-C and CRP identify different high-risk groups

A: Epidemiology update. Evidence that LDL-C and CRP identify different high-risk groups A: Epidemiology update Evidence that LDL-C and CRP identify different high-risk groups Women (n = 27,939; mean age 54.7 years) who were free of symptomatic cardiovascular (CV) disease at baseline were

More information